Status:
UNKNOWN
Clinical Implications of FKBP5 in Stroke
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
Stroke
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
With contemporary lifestyle changes and global aging, it is important yet unknown how stress interacts to post-stroke outcomes. This proposal aims to study the link between the stress-responsive FKBP5...
Detailed Description
Stress is an underestimated risk factor and also a consequence of cardiovascular diseases and stroke. FK506-binding protein 51 (FKBP51) modulates stress responses by acting as a co-chaperone that nega...
Eligibility Criteria
Inclusion
- Unilateral ischemic or hemorrhagic stroke
- Aged 20-80 years old
Exclusion
- FMA-UE is over 49 points
- Major psychiatric diseases
- Major neurologic diseases
- Global aphasia
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05198037
Start Date
November 1 2021
End Date
July 1 2025
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Taiwan, 112